Nantes Cedex 3, 44313
France
University of Nantes, Law School
Product liability, Pharmaceutical product, Hepatitis B vaccine, Demyelinating disease, Multiple sclerosis, Guillain-Barré syndrome, Causality, Causation, Imputability, Presumptions, Risk-benefit ratio
immigration law, judicial equity,ethnicisation,human rights,Product liability, Pharmaceutical product, Hepatitis B vaccine, Demyelinating disease, Financial Investors,Consumers,Italian Legislation
